2l6t
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
[[Image:2l6t.png|left|200px]] | [[Image:2l6t.png|left|200px]] | ||
| - | <!-- | ||
| - | The line below this paragraph, containing "STRUCTURE_2l6t", creates the "Structure Box" on the page. | ||
| - | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
| - | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
| - | or leave the SCENE parameter empty for the default display. | ||
| - | --> | ||
{{STRUCTURE_2l6t| PDB=2l6t | SCENE= }} | {{STRUCTURE_2l6t| PDB=2l6t | SCENE= }} | ||
===Efficacy of an HIV-1 entry inhibitor targeting the GP41 fusion peptide=== | ===Efficacy of an HIV-1 entry inhibitor targeting the GP41 fusion peptide=== | ||
| - | |||
| - | <!-- | ||
| - | The line below this paragraph, {{ABSTRACT_PUBMED_21178138}}, adds the Publication Abstract to the page | ||
| - | (as it appears on PubMed at http://www.pubmed.gov), where 21178138 is the PubMed ID number. | ||
| - | --> | ||
{{ABSTRACT_PUBMED_21178138}} | {{ABSTRACT_PUBMED_21178138}} | ||
| Line 22: | Line 11: | ||
==Reference== | ==Reference== | ||
| - | <ref group="xtra">PMID: | + | <ref group="xtra">PMID:021178138</ref><ref group="xtra">PMID:017448989</ref><references group="xtra"/> |
[[Category: Adermann, K.]] | [[Category: Adermann, K.]] | ||
[[Category: Albrecht, U.]] | [[Category: Albrecht, U.]] | ||
| Line 40: | Line 29: | ||
[[Category: The, Y.]] | [[Category: The, Y.]] | ||
[[Category: Les-Mayordomo, A Can.]] | [[Category: Les-Mayordomo, A Can.]] | ||
| + | [[Category: Anti-viral polypeptide]] | ||
| + | [[Category: Antiviral protein]] | ||
| + | [[Category: Fp1-24]] | ||
| + | [[Category: Gp41 fusion peptide]] | ||
Revision as of 13:15, 30 January 2013
Efficacy of an HIV-1 entry inhibitor targeting the GP41 fusion peptide
Template:ABSTRACT PUBMED 21178138
About this Structure
2l6t is a 1 chain structure. Full experimental information is available from OCA.
Reference
- Forssmann WG, The YH, Stoll M, Adermann K, Albrecht U, Barlos K, Busmann A, Canales-Mayordomo A, Gimenez-Gallego G, Hirsch J, Jimenez-Barbero J, Meyer-Olson D, Munch J, Perez-Castells J, Standker L, Kirchhoff F, Schmidt RE. Short-term monotherapy in HIV-infected patients with a virus entry inhibitor against the gp41 fusion peptide. Sci Transl Med. 2010 Dec 22;2(63):63re3. PMID:21178138 doi:10.1126/scitranslmed.3001697
- Munch J, Standker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pohlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F. Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide. Cell. 2007 Apr 20;129(2):263-75. PMID:17448989 doi:S0092-8674(07)00328-5
Categories: Adermann, K. | Albrecht, U. | Barlos, K. | Busmann, A. | Forssmann, W. | Gimenez-Gallego, G. | Hirsch, J. | Jimenez-Barbero, J. | Kirchhoff, F. | Meyer-Olson, D. | Muench, J. | Perez-Castells, J. | Schmidt, R E. | Staendker, L. | Stoll, M. | The, Y. | Les-Mayordomo, A Can. | Anti-viral polypeptide | Antiviral protein | Fp1-24 | Gp41 fusion peptide
